Doximity Inc. (DOCS) attracts a new wave of investors despite economic turmoil

Doximity Inc. (NYSE: DOCS) closed the day trading at 31.03 up 2.04% from the previous closing price of $30.41. In other words, the price has increased by $+0.62 from its previous closing price. On the day, 1679104 shares were traded. DOCS reached its highest trading level at $32.10 during the session, while it also had its lowest trading level at $30.26.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Ratios:

For a better understanding of DOCS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.20 and its Current Ratio is at 7.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On September 07, 2022, Truist started tracking the stock assigning a Hold rating and target price of $35.

BofA Securities Downgraded its Neutral to Underperform on August 05, 2022, whereas the target price for the stock was revised from $43 to $29.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 27 when Tangney Jeffrey bought 2,950 shares for $34.50 per share. The transaction valued at 101,775 led to the insider holds 252,950 shares of the business.

Jorgensen Paul W. bought 15,000 shares of DOCS for $482,864 on May 20. The Chief Revenue Officer now owns 197,676 shares after completing the transaction at $32.19 per share. On May 02, another insider, Wampler Kira Scherer, who serves as the Director of the company, sold 2,200 shares for $39.88 each. As a result, the insider received 87,727 and left with 0 shares of the company.

Valuation Measures:

As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.65, and their Forward P/E ratio for the next fiscal year is 36.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 12.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.24 while its Price-to-Book (P/B) ratio in mrq is 6.63.

Stock Price History:

Over the past 52 weeks, DOCS has reached a high of $91.25, while it has fallen to a 52-week low of $27.06. The 50-Day Moving Average of the stock is 37.19, while the 200-Day Moving Average is calculated to be 43.64.

Shares Statistics:

Over the past 3-months, DOCS traded about 1.92M shares per day on average, while over the past 10 days, DOCS traded about 1.52M shares per day. A total of 192.95M shares are outstanding, with a floating share count of 107.83M. Insiders hold about 1.00% of the company’s shares, while institutions hold 93.80% stake in the company. Shares short for DOCS as of Jul 14, 2022 were 18.3M with a Short Ratio of 8.71, compared to 12.56M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 9.46% and a Short% of Float of 19.83%.

Earnings Estimates

Current recommendations for the stock of the company come from 9 analysts. On average, analysts expect EPS of $0.1 for the current quarter, with a high estimate of $0.12 and a low estimate of $0.07, while EPS last year was $0.11. The consensus estimate for the next quarter is $0.15, with high estimates of $0.19 and low estimates of $0.1.

Analysts are recommending an EPS of between $1.05 and $0.66 for the fiscal current year, implying an average EPS of $0.75. EPS for the following year is $0.94, with 10 analysts recommending between $1.32 and $0.8.

Revenue Estimates

11 analysts predict $89.3M in revenue for the current quarter. It ranges from a high estimate of $90.24M to a low estimate of $88.95M. As of the current estimate, Doximity Inc.’s year-ago sales were $63.61M, an estimated increase of 40.40% from the year-ago figure.

A total of 14 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $457.8M, while the lowest revenue estimate was $445.47M, resulting in an average revenue estimate of $455.13M. In the same quarter a year ago, actual revenue was $343.55M, up 32.50% from the average estimate. Based on 14 analysts’ estimates, the company’s revenue will be $586M in the next fiscal year. The high estimate is $614M and the low estimate is $567.6M. The average revenue growth estimate for next year is up 28.80% from the average revenue estimate for this year.